A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.

about

Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease.

P2860

Q47127905-EA081939-B062-4BE0-A27A-CE97425E706B

P2860

A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q38654282

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A study on the risk of fungal ...... gent for rheumatoid arthritis.

@en

type

Item

label

A study on the risk of fungal ...... gent for rheumatoid arthritis.

@en

prefLabel

A study on the risk of fungal ...... gent for rheumatoid arthritis.

@en

P1476

A study on the risk of fungal ...... gent for rheumatoid arthritis.

@en

P2093

Fang-Yuan Gong

http://www.w3.org/2001/XMLSchema#string

Shu-Yan Ma

http://www.w3.org/2001/XMLSchema#string

Xiao-Ming Gao

http://www.w3.org/2001/XMLSchema#string

Yong Chen

http://www.w3.org/2001/XMLSchema#string

Zhe Zhou

http://www.w3.org/2001/XMLSchema#string

Zhen-Jun Li

http://www.w3.org/2001/XMLSchema#string

Zheng Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans.

Chronic granulomatous disease. Report on a national registry of 368 patients.

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes.

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors

JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

P2888

s41598-017-07261-1

P304

6779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-07261-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090883010

http://www.w3.org/2001/XMLSchema#string

P698

28754958

http://www.w3.org/2001/XMLSchema#string

P932

5533717

http://www.w3.org/2001/XMLSchema#string

A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.

about

P2860

P2860

A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932